Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06541457
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
A Study on Safety Tolerability Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
To Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of HRS-7249 in Healthy Subjects - a Randomized Double-blind Dose-increasing Placebo-controlled Phase I Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is a randomized double-blind single-dose placebo-controlled phase I clinical trial The study plans to conduct four to six dose groups of dose 1 dose 2 dose 3 dose4 dose5 optional and dose 6optional Eight subjects will be enrolled for each dose group with six administered HRS-7249 injection and two administered placebo A total of 32 to 48 healthy subjects are planned to be enrolled
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None